Transaction in Own Shares

Spectris PLC
25 August 2023
 

25 August 2023

Spectris plc (SXS: LSE) ('Spectris')

Purchase of own shares

Spectris announces that on 25 August 2023 it purchased the following number of its ordinary shares of 5p each on the London Stock Exchange and other recognised investment exchanges from Merrill Lynch International as part of the buyback programme announced on 01 August 2023.

Platform

London Stock Exchange

Cboe BXE

Cboe CXE

Turquoise

Aquis

Aggregate number of shares purchased

43,040

0

0

0

0

Lowest price paid per share

3,255.00p

0.00p

0.00p

0.00p

0.00p

Highest price paid per share

3,279.00p

0.00p

0.00p

0.00p

0.00p

Average price paid per share

3,268.08p

0.00p

0.00p

0.00p

0.00p


Spectris intends to cancel the purchased shares.

As at the date of the above purchase, Spectris had 103,455,047 ordinary shares of 5p each in issue (excluding 4,171,801 ordinary shares of 5p each held in treasury). This number represents the total voting rights in Spectris and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, Spectris under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Merrill Lynch International as part of the buyback programme.

LEI Number: 213800Z4CO2CZO3M3T10

Enquiries to:

Spectris plc

Mathew Wootton

Director of Investor Relations
+44 75000 78880

Amy Clapton

Deputy Company Secretary

+ 44 74252 09075

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Spectris (SXS)
UK 100

Latest directors dealings